Analystreport

GlaxoSmithKline (NYSE: GSK) was upgraded by analysts at BNP Paribas from a "neutral" rating to an "outperform" rating.

GSK plc American Depositary Shares (Each representing two Ordinary Shares)  (GSK) 
US:NYSE Investor Relations: gsk.com/en-gb/investors